Abstract:Abstract Unraveling the molecular nature of skin aging and keratinocyte senescence represents a challenging research project in epithelial biology. In this regard, depletion of p63, a p53 family transcription factor prominently expressed in human and mouse epidermis, accelerates both aging and the onset of senescence markers in vivo animal models as well as in ex vivo keratinocytes. Nonetheless, the biochemical link between p63 action and senescence phenotype remains largely unexplored. In the present study, through ultrahigh performance liquid chromatography–tandem mass spectroscopy (UPLC–MS/MS) and gas chromatography/mass spectrometry (GC/MS) metabolomic analysis, we uncover interesting pathways linking replicative senescence to metabolic alterations during p63 silencing in human keratinocytes. Integration of our metabolomic profiling data with targeted transcriptomic investigation empowered us to demonstrate that absence of p63 and senescence share similar modulation profiles of oxidative stress markers, pentose phosphate pathway metabolites and lyso-glycerophospholipids, the latter due to enhanced phospholipases gene expression profile often under p63 direct/indirect gene control. Additional biochemical features identified in deranged keratinocytes include a relevant increase in lipids production, glucose and pyruvate levels as confirmed by upregulation of gene expression of key lipid synthesis and glycolytic enzymes, which, together with improved vitamins uptake, characterize senescence phenotype. Silencing of p63 in keratinocytes instead, translates into a blunted flux of metabolites through both glycolysis and the Krebs cycle, likely due to a p63-dependent reduction of hexokinase 2 and citrate synthase gene expression. Our findings highlight the potential role of p63 in counteracting keratinocyte senescence also through fine regulation of metabolite levels and relevant biochemical pathways. We believe that our research might contribute significantly to the discovery of new implications of p63 in keratinocyte senescence and related diseases.

Master regulatory role of p63 in epidermal development and disease

Gene regulatory mechanisms orchestrated by p63 in epithelial development and related disorders

Molecular and Cellular Function of p63 in Skin Development and Genetic Diseases

p63 in corneal and epidermal differentiation

Role of P63 in Development, Tumorigenesis and Cancer Progression

Single-cell RNA-seq Identifies a Reversible Epithelial-Mesenchymal Transition in Abnormally Specified Epithelia of P63 EEC Syndrome

Pathway Regulation of p63, a Director of Epithelial Cell Fate

Genome-wide analysis of p63 binding sites identifies AP-2 factors as co-regulators of epidermal differentiation

P63 in health and cancer

Tp63 in Oral Development, Neoplasia, and Autoimmunity

The Dual Role of P63 in Cancer

p63: a crucial player in epithelial stemness regulation

Disease-related p63 DBD mutations impair DNA binding by distinct mechanisms and varying degree

TP63 Links Chromatin Remodeling and Enhancer Reprogramming to Epidermal Differentiation and Squamous Cell Carcinoma Development

p63-related signaling at a glance

P63 Affects Distinct Metabolic Pathways During Keratinocyte Senescence, Evaluated by Metabolomic Profile and Gene Expression Analysis

Pirh2 E3 Ubiquitin Ligase Modulates Keratinocyte Differentiation through p63

Epigenetic regulation of p63 blocks squamous-to-neuroendocrine transdifferentiation in esophageal development and malignancy

The Transcription Factor p63 Is a Direct Effector of IL-4- and IL-13-Mediated Repression of Keratinocyte Differentiation

Identification and functional characterization of two new transcriptional variants of the human p63 gene

Regulation of skin aging and heart development by TAp63